Synthon Holdings BV-製薬・医療分野:企業M&A・提携分析

◆英語タイトル:Synthon Holdings BV - Pharmaceuticals & Healthcare - Deals and Alliances Profile
◆商品コード:DATA8013341
◆発行会社(調査会社):GlobalData
◆発行日:2017年11月28日
◆ページ数:30
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:オランダ
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single UserUSD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
Synthon Holdings BV (Synthon) is an integrated pharmaceutical company which focuses on delivering affordable medicines through innovative science. The company undertakes the research, development, manufacture and distribution of generics, active pharmaceutical ingredients and biopharmaceutical products. It provides small molecule generic products in the therapeutic areas of allergy, anti-infective, cardiovascular, central nervous system, oncology, skeletal and urology. The company’s products are approved by regulatory agencies in over 90 countries. It operates research and development facilities and manufacturing facilities to carry out its operations. The company has presence in Chile, Czech Republic, Mexico, Russia, Spain, Argentina and the US. Synthon is headquartered in Nijmegen, the Netherlands.

Synthon Holdings BV – Pharmaceuticals & Healthcare – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
Synthon Holdings BV, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 5
Synthon Holdings BV, Pharmaceuticals & Healthcare Deals By Type, 2011 to YTD 2017 6
Synthon Holdings BV, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 7
Synthon Holdings BV, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2011 to YTD 2017 8
Synthon Holdings BV, Medical Devices Deals, 2011 to YTD 2017 9
Synthon Holdings BV, Pharmaceuticals & Healthcare, Deals Summary, 2011 to YTD 2017 10
Synthon Holdings BV, Pharmaceuticals & Healthcare, Deal Details 11
Asset Purchase 11
Synthon Acquires LEX System From Biolex Therapeutics 11
Partnerships 13
Pfizer Enters into Agreement with Synthon 13
MAB Discovery Enters into Research Agreement with Synthon for Antibodies 14
Synthon Enters Into Drug Discovery Agreement With MIVAC Development 15
Synthon Enters Into Research And Development Agreement With MIVAC 16
Licensing Agreements 17
Synthon Biopharma Enters into Licensing Agreement with Sanquin Blood Supply Foundation 17
MacroGenics Enters into Licensing Agreement with Synthon Biopharma 18
Synthon Enters Into Licensing Agreement With Amgen And Watson Pharma For Trastuzumab 19
Asset Transactions 21
Mercachem to Acquire Laboratory and Pilot Scale Operations in Prague from Synthon 21
Acquisition 22
Synthon Acquires Syntarga 22
Synthon Holdings BV – Key Competitors 24
Synthon Holdings BV – Key Employees 25
Synthon Holdings BV – Locations And Subsidiaries 26
Head Office 26
Other Locations & Subsidiaries 26
Recent Developments 28
Clinical Trials 28
May 18, 2016: Synthon advances clinical evaluation of anti-HER2 ADC SYD985 in an expanded cohort of HER2-positive metastatic breast cancer patients 28
Appendix 30
Methodology 30
About GlobalData 30
Contact Us 30
Disclaimer 30

List of Tables
Synthon Holdings BV, Pharmaceuticals & Healthcare, Key Facts 2
Synthon Holdings BV, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 5
Synthon Holdings BV, Pharmaceuticals & Healthcare Deals By Type, 2011 to YTD 2017 6
Synthon Holdings BV, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 7
Synthon Holdings BV, Deals By Therapy Area, 2011 to YTD 2017 8
Synthon Holdings BV, Medical Devices Deals, 2011 to YTD 2017 9
Synthon Holdings BV, Pharmaceuticals & Healthcare, Deals Summary, 2011 to YTD 2017 10
Synthon Acquires LEX System From Biolex Therapeutics 11
Pfizer Enters into Agreement with Synthon 13
MAB Discovery Enters into Research Agreement with Synthon for Antibodies 14
Synthon Enters Into Drug Discovery Agreement With MIVAC Development 15
Synthon Enters Into Research And Development Agreement With MIVAC 16
Synthon Biopharma Enters into Licensing Agreement with Sanquin Blood Supply Foundation 17
MacroGenics Enters into Licensing Agreement with Synthon Biopharma 18
Synthon Enters Into Licensing Agreement With Amgen And Watson Pharma For Trastuzumab 19
Mercachem to Acquire Laboratory and Pilot Scale Operations in Prague from Synthon 21
Synthon Acquires Syntarga 22
Synthon Holdings BV, Key Competitors 24
Synthon Holdings BV, Key Employees 25
Synthon Holdings BV, Subsidiaries 26

★海外企業調査レポート[Synthon Holdings BV-製薬・医療分野:企業M&A・提携分析]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • KT Corporation:企業のM&A・事業提携・投資動向
    KT Corporation - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's KT Corporation Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions (M&A), divestmen …
  • Talktalk Telecom Group PLC (TALK):企業の戦略的SWOT分析
    Talktalk Telecom Group PLC (TALK) - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major p …
  • Opthea Ltd (OPT):企業の財務・戦略的SWOT分析
    Summary Opthea Ltd (Opthea), formerly Circadian Technologies Ltd, is a biotechnology company that develops novel biologic therapy for the treatment of eye diseases. The company carries out research and development of angiogenesis and vascular leakage-based treatments for cancer concentrating on vasc …
  • Microsoft Corp (MSFT):医療機器:M&Aディール及び事業提携情報
    Summary Microsoft Corporation (Microsoft) is a technology-based company that develops, licenses, and supports software products, services, and devices. The company offers a comprehensive range of operating systems, cross-device productivity applications, server applications, business solution applic …
  • NetApp Inc:企業の戦略・SWOT・財務情報
    NetApp Inc - Strategy, SWOT and Corporate Finance Report Summary NetApp Inc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actio …
  • Heroux-Devtek Inc.:企業の戦略・SWOT・財務情報
    Heroux-Devtek Inc. - Strategy, SWOT and Corporate Finance Report Summary Heroux-Devtek Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and …
  • Cheung Kong Infrastructure Holdings Ltd:企業の戦略・SWOT・財務情報
    Cheung Kong Infrastructure Holdings Ltd - Strategy, SWOT and Corporate Finance Report Summary Cheung Kong Infrastructure Holdings Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT a …
  • The Goldman Sachs Group Inc (GS):企業の財務・戦略的SWOT分析
    The Goldman Sachs Group Inc (GS) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and wea …
  • Take-Two Interactive Software, Inc.
    Take-Two Interactive Software, Inc. - Strategy, SWOT and Corporate Finance Report Summary Take-Two Interactive Software, Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, …
  • Symphogen AS:企業の戦略的SWOT分析
    Symphogen AS - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and services. …
  • Hindustan ZInc Ltd:企業の戦略・SWOT・財務情報
    Hindustan ZInc Ltd - Strategy, SWOT and Corporate Finance Report Summary Hindustan ZInc Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and …
  • Castle Brands Inc.:企業の戦略・SWOT・財務分析
    Castle Brands Inc. - Strategy, SWOT and Corporate Finance Report Summary Castle Brands Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and …
  • Micron Technology Inc:企業の戦略・SWOT・財務分析
    Micron Technology Inc - Strategy, SWOT and Corporate Finance Report Summary Micron Technology Inc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerin …
  • University of Chicago-製薬・医療分野:企業M&A・提携分析
    Summary University of Chicago (UOC) is an academic and research university that offers education and research in various disciplines. The university offers undergraduate, master’s and PhD programs in the areas of anthropology, art history, astronomy and astrophysics, biochemistry and molecular biolo …
  • Autobahn Tank & Rast Holding GmbH:企業の戦略・SWOT・財務情報
    Autobahn Tank & Rast Holding GmbH - Strategy, SWOT and Corporate Finance Report Summary Autobahn Tank & Rast Holding GmbH - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, pro …
  • Nasser S. Al –Hajri Corp:企業の戦略的SWOT分析
    Nasser S. Al –Hajri Corp - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products a …
  • Gulf Island Fabrication Inc (GIFI):企業の財務・戦略的SWOT分析
    Gulf Island Fabrication Inc (GIFI) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and w …
  • Selvita SA (SLV):製薬・医療:M&Aディール及び事業提携情報
    Summary Selvita SA (Selvita) is a drug discovery company that focuses on the research and development of cancer therapies. The company develops novel small molecule drugs, and markets them with partners from the pharmaceutical industry. Its products find application in the therapeutic areas of oncol …
  • Mettler-Toledo International Inc:企業の戦略・SWOT・財務情報
    Mettler-Toledo International Inc - Strategy, SWOT and Corporate Finance Report Summary Mettler-Toledo International Inc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, produ …
  • Alchemia Ltd (ACL):製薬・医療:M&Aディール及び事業提携情報
    Summary Alchemia Ltd (Alchemia) is an early stage biopharmaceutical company that focuses on the discovery and development of drugs for the treatment of various diseases. It sold the worldwide exclusive intellectual property rights to its product, Fondaparinux sodium (a generic version of the anticoa …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆